Hugh Bettesworth (Chief Executive) has worked in the software industry for over fifteen years, the last 12 in the clinical sector. He joined Mirada in 2001, and took over the development of the company’s image fusion product lines in 2003. Following Mirada’s acquisition by first CTI Molecular Imaging and then Siemens Molecular Imaging, Hugh continued to develop the market for these products focussing on the delivery of specialist molecular imaging workflows into new markets and in particular the PACS market. He led a management buyout in 2008 which re-established Mirada’s independent status and provided the platform for the innovative software developments which have resulted in Mirada’s subsequent growth and leading technical position today.

Gail Buswell (Chief Financial & Operating Officer) graduated from Edinburgh University with an MA Honours in Geography and subsequently joined the graduate recruitment programme at PricewaterhouseCoopers (then Coopers & Lybrand). She worked in the growing business department in Reading for 4 years and became a qualified chartered accountant (ACA ICAEW) in December 2000. On qualifying Gail moved to the PwC Sydney office for 3 years where she managed a portfolio of SME clients. Gail returned to her home town of Oxford in January 2004 and joined CTI Europe as their European Financial Controller; a role that included controlling the finance function for Mirada Solutions as well as CTI subsidiaries in Germany, Spain and Italy and Petnet in the UK. She assisted with the integration of Mirada and CTI Europe into Siemens following the 2005 acquisition and then in January 2007 left Siemens to join SQW Group, as Group Financial Controller, to assist with the integration of the consultancy business SQW and Oxford Innovation. In April 2009 Gail joined the team at Mirada Medical as Finance Director and Chief Operations Officer, bringing with her extensive experience with growing businesses.

 Prof. Sir Michael Brady FRS, FREng, FMedSci is now Professor Emeritus of Radiation Oncology and Biology, having retired as Professor of Information Engineering at the University of Oxford. He combines his work at Oxford University, where he founded the Robotics Laboratory and the Medical Vision Laboratory (MVL), with a range of entrepreneurial activities. He is a non-executive director of AEA Technology and Isis Innovation (Oxford University's intellectual property company) and was also a founding director of successful start-up companies such as Guidance and, of course, Mirada Medical. He is a Fellow of the Institution of Electrical Engineers and a founding Fellow of the Association of Artificial Intelligence. He is also a Fellow of the Institute of Physics, and a Fellow of the British Computing Society. He was awarded the IEE Faraday Medal in 2000 and also the IEEE Third Millennium Medal for the UK. In 2005 the Royal Institution awarded Professor Sir Michael Brady the Henry Dale Prize for "outstanding work on a biological topic by means of an original multidisciplinary approach".

Mark Evans FCA, MCT, MBA is a Chartered Accountant (UK equivalent to a CPA), a qualified Corporate Treasurer and holds an MBA from Saïd Business School, Oxford University. Mark’s experience runs from technology start-ups to being a CFO responsible for a EUR 800m business within a multi-national corporation. Mark’s experience in medical technology includes being European Finance Director for CTI Molecular Imaging; COO then MD of Mirada Solutions Ltd, a medical imaging software company; MD of PETNET Solutions in the UK, a radiopharmaceutical production company; and Vice President and European CFO of a 26 market region of Siemens Diagnostics.

David Gudgin qualified as a management accountant with ICL before spending 3 years at the BBC. In 1999 he joined 3i as an investor in European technology based in London and Amsterdam. In 2002 he moved to Foursome Investments (now Frog Capital) as the lead investor of two funds, an environmental technology fund and a later stage development capital fund. David joined Close Ventures in 2005 and became a partner in Albion Ventures in 2009. David has a Bsc in Economics from Warwick University.